Leukemia inhibitory factor stimulates vasopressin release in rats

Seiji Ishizaki, Takashi Murase, Yoshihisa Sugimura, Ryoichi Banno, Hiroshi Arima, Yoshitaka Miura, Yutaka Oiso

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Leukemia inhibitory factor (LIF) is a cytokine of the interleukin-6 family exhibiting diverse physiological functions during inflammatory stress. It is well known that syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is often associated with inflammatory disease, and cytokines produced at inflammatory foci are thought to stimulate arginine vasopressin (AVP) release. In the present study, we investigated the effects of centrally administered LIF on AVP release in conscious rats. Intracerebroventricular administration of LIF (0.01-1.0 μg/rat) significantly increased the plasma AVP concentration, and its effect was observed from 5 to 60 min after the injection. LIF did not cause significant changes in plasma Na + , total protein and blood pressure. There were no significant changes in the plasma AVP concentration after intravenous injection of LIF (1.0, 3.0 μg/rat). These results indicate that LIF plays a stimulatory role in the regulation of AVP release, and suggest the possibility that LIF may be involved in the pathogenesis of SIADH.

Original languageEnglish
Pages (from-to)77-80
Number of pages4
JournalNeuroscience Letters
Volume359
Issue number1-2
DOIs
Publication statusPublished - 08-04-2004

Fingerprint

Leukemia Inhibitory Factor
Vasopressins
Arginine Vasopressin
Cytokines
Inappropriate ADH Syndrome
Intravenous Injections
Interleukin-6
Blood Pressure
Injections

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Ishizaki, S., Murase, T., Sugimura, Y., Banno, R., Arima, H., Miura, Y., & Oiso, Y. (2004). Leukemia inhibitory factor stimulates vasopressin release in rats. Neuroscience Letters, 359(1-2), 77-80. https://doi.org/10.1016/j.neulet.2004.02.019
Ishizaki, Seiji ; Murase, Takashi ; Sugimura, Yoshihisa ; Banno, Ryoichi ; Arima, Hiroshi ; Miura, Yoshitaka ; Oiso, Yutaka. / Leukemia inhibitory factor stimulates vasopressin release in rats. In: Neuroscience Letters. 2004 ; Vol. 359, No. 1-2. pp. 77-80.
@article{55f4b02f06674daea1cbcfc1dd86c278,
title = "Leukemia inhibitory factor stimulates vasopressin release in rats",
abstract = "Leukemia inhibitory factor (LIF) is a cytokine of the interleukin-6 family exhibiting diverse physiological functions during inflammatory stress. It is well known that syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is often associated with inflammatory disease, and cytokines produced at inflammatory foci are thought to stimulate arginine vasopressin (AVP) release. In the present study, we investigated the effects of centrally administered LIF on AVP release in conscious rats. Intracerebroventricular administration of LIF (0.01-1.0 μg/rat) significantly increased the plasma AVP concentration, and its effect was observed from 5 to 60 min after the injection. LIF did not cause significant changes in plasma Na + , total protein and blood pressure. There were no significant changes in the plasma AVP concentration after intravenous injection of LIF (1.0, 3.0 μg/rat). These results indicate that LIF plays a stimulatory role in the regulation of AVP release, and suggest the possibility that LIF may be involved in the pathogenesis of SIADH.",
author = "Seiji Ishizaki and Takashi Murase and Yoshihisa Sugimura and Ryoichi Banno and Hiroshi Arima and Yoshitaka Miura and Yutaka Oiso",
year = "2004",
month = "4",
day = "8",
doi = "10.1016/j.neulet.2004.02.019",
language = "English",
volume = "359",
pages = "77--80",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

Ishizaki, S, Murase, T, Sugimura, Y, Banno, R, Arima, H, Miura, Y & Oiso, Y 2004, 'Leukemia inhibitory factor stimulates vasopressin release in rats', Neuroscience Letters, vol. 359, no. 1-2, pp. 77-80. https://doi.org/10.1016/j.neulet.2004.02.019

Leukemia inhibitory factor stimulates vasopressin release in rats. / Ishizaki, Seiji; Murase, Takashi; Sugimura, Yoshihisa; Banno, Ryoichi; Arima, Hiroshi; Miura, Yoshitaka; Oiso, Yutaka.

In: Neuroscience Letters, Vol. 359, No. 1-2, 08.04.2004, p. 77-80.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Leukemia inhibitory factor stimulates vasopressin release in rats

AU - Ishizaki, Seiji

AU - Murase, Takashi

AU - Sugimura, Yoshihisa

AU - Banno, Ryoichi

AU - Arima, Hiroshi

AU - Miura, Yoshitaka

AU - Oiso, Yutaka

PY - 2004/4/8

Y1 - 2004/4/8

N2 - Leukemia inhibitory factor (LIF) is a cytokine of the interleukin-6 family exhibiting diverse physiological functions during inflammatory stress. It is well known that syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is often associated with inflammatory disease, and cytokines produced at inflammatory foci are thought to stimulate arginine vasopressin (AVP) release. In the present study, we investigated the effects of centrally administered LIF on AVP release in conscious rats. Intracerebroventricular administration of LIF (0.01-1.0 μg/rat) significantly increased the plasma AVP concentration, and its effect was observed from 5 to 60 min after the injection. LIF did not cause significant changes in plasma Na + , total protein and blood pressure. There were no significant changes in the plasma AVP concentration after intravenous injection of LIF (1.0, 3.0 μg/rat). These results indicate that LIF plays a stimulatory role in the regulation of AVP release, and suggest the possibility that LIF may be involved in the pathogenesis of SIADH.

AB - Leukemia inhibitory factor (LIF) is a cytokine of the interleukin-6 family exhibiting diverse physiological functions during inflammatory stress. It is well known that syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is often associated with inflammatory disease, and cytokines produced at inflammatory foci are thought to stimulate arginine vasopressin (AVP) release. In the present study, we investigated the effects of centrally administered LIF on AVP release in conscious rats. Intracerebroventricular administration of LIF (0.01-1.0 μg/rat) significantly increased the plasma AVP concentration, and its effect was observed from 5 to 60 min after the injection. LIF did not cause significant changes in plasma Na + , total protein and blood pressure. There were no significant changes in the plasma AVP concentration after intravenous injection of LIF (1.0, 3.0 μg/rat). These results indicate that LIF plays a stimulatory role in the regulation of AVP release, and suggest the possibility that LIF may be involved in the pathogenesis of SIADH.

UR - http://www.scopus.com/inward/record.url?scp=1842452029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842452029&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2004.02.019

DO - 10.1016/j.neulet.2004.02.019

M3 - Article

C2 - 15050716

AN - SCOPUS:1842452029

VL - 359

SP - 77

EP - 80

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1-2

ER -